What is ThoroughCare?
Founded in 2013, ThoroughCare operates at the intersection of clinical expertise and software innovation. The company is composed of a multidisciplinary team of entrepreneurs, clinicians, and technologists who possess decades of collective experience in the healthcare software domain. Their primary mission is to empower healthcare organizations to thrive in an increasingly complex regulatory and operational environment, specifically by providing tools that facilitate proactive patient health management. By bridging the gap between data-driven insights and clinical workflows, ThoroughCare enables providers to improve patient outcomes while simultaneously optimizing operational efficiency. Their market position is characterized by a focus on high-impact, scalable solutions that address the critical needs of modern healthcare delivery systems.
How much funding has ThoroughCare raised?
ThoroughCare has raised a total of $13.3M across 4 funding rounds:
Other Financing Round
$3M
Series A
$5M
Stock/Share Issuance
$3M
Stock/Share Issuance
$2.3M
Other Financing Round (2022): $3M with participation from Cypress Growth Capital
Series A (2024): $5M led by Empactful Capital
Stock/Share Issuance (2025): $3M, investors not publicly disclosed
Stock/Share Issuance (2026): $2.3M, investors not publicly disclosed
Key Investors in ThoroughCare
Empactful Capital
Formed in 2016 by veteran healthcare operators, Empactful Capital deploys targeted funds to provide operating and relationship leverage to companies looking to scale rapidly.
Cypress Growth Capital
Cypress Growth Capital specializes in royalty-based funding, offering flexible and non-dilutive growth capital tailored for emerging companies in the SaaS and tech-enabled services sectors.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for ThoroughCare?
With the successful closure of its latest funding round, ThoroughCare is well-positioned to accelerate its product development roadmap and expand its market reach. The strategic focus will likely shift toward deepening the integration of its software within existing enterprise health systems, thereby increasing the stickiness of its platform. Furthermore, the company is expected to leverage this capital to enhance its data analytics capabilities, allowing for more predictive and personalized patient care models. As ThoroughCare continues to scale, the emphasis will remain on maintaining its reputation for clinical excellence while navigating the complexities of the broader healthcare technology ecosystem. The firm's ability to secure consistent backing suggests a high level of investor confidence in its long-term vision and its capacity to deliver sustained value in the digital health sector.
See full ThoroughCare company page
